Non-steroidal Anti-inflammatory Drugs (NSAID) Market size was valued at USD 34.4 Billion in 2024 and is projected to reach USD 45.2 Billion by 2033, exhibiting a CAGR of 3.6% from 2026 to 2033.
The global Non steroidal Anti inflammatory Drugs (NSAID) market was valued at USD 12.25 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2023 to 2030. This growth is attributed to the increasing prevalence of chronic pain, osteoarthritis, and inflammatory diseases worldwide. The demand for over the counter NSAIDs and prescription based drugs is escalating due to their efficacy in treating a wide range of conditions such as arthritis, muscle pain, and headaches. Moreover, the aging population, particularly in North America and Europe, is contributing to the rising market size, with an expected market value of USD 20.45 billion by 2030. The shift towards non prescription NSAIDs, as well as the development of novel formulations for improved patient compliance, is driving the market forward.
Regionally, North America held the largest market share in 2022, accounting for approximately 35% of the global NSAID market. This dominance can be attributed to high healthcare expenditures, a well established pharmaceutical industry, and a large number of patients suffering from arthritis and other musculoskeletal disorders. The Asia Pacific region is anticipated to witness the highest growth rate during the forecast period, driven by a growing geriatric population, increasing disposable income, and improving healthcare infrastructure. The market in Europe is expected to grow steadily, driven by rising health awareness and the adoption of NSAIDs in treating various chronic conditions. Opportunities in emerging economies in Latin America and the Middle East are also becoming prominent due to rising healthcare access and awareness of the benefits of NSAIDs.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=482503&utm_source=Pulse_G_April&utm_medium=212
Bayer
Ecotrin
Generic
St. Joseph
Elanco
Zoetis
Boehringer Ingelheim
Merial
Merck Animal Health
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=482503&utm_source=Pulse_G_April&utm_medium=212
Growing demand for below applications around the world has had a direct impact on the growth of the Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market
Non-selective NSAIDs
Selective COX-2 Inhibitors
Salicylates
Oral
Topical
Injectable
Rectal
Acute Pain
Chronic Pain
Adults
Pediatrics
Geriatrics
Tablets
Capsules
Gel
Ointment
Syrup
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/non-steroidal-anti-inflammatory-drugs-nsaid-market-size-and-forecast/
1. Introduction of the Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, By Type
6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, By Application
7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/